Ignite Creation Date:
2024-05-06 @ 12:36 PM
Last Modification Date:
2024-10-26 @ 1:01 PM
Study NCT ID:
NCT03800836
Status:
COMPLETED
Last Update Posted:
2022-04-25
First Post:
2019-01-07
Brief Title:
A Study to Evaluate the Safety and Efficacy of Ipatasertib in Combination With Atezolizumab and Paclitaxel or Nab-Paclitaxel in Participants With Locally Advanced or Metastatic Triple-Negative Breast Cancer
Sponsor:
Hoffmann-La Roche
Organization:
Hoffmann-La Roche
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-02-13
Start Date Type:
ACTUAL
Primary Completion Date:
2022-03-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-03-15
Completion Date Type:
ACTUAL
First Submit Date:
2019-01-07
First Submit QC Date:
January 9 2019
Study First Post Date:
2019-01-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-04-22
Last Update Post Date:
2022-04-25
Last Update Post Date Type:
ACTUAL